Heme, a molecule crucial for several biological processes, is transported from sites of production or storage for use in…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Impairments in endothelial cells — those that line blood vessels — are more likely to be found in people with…
Almost all people with severe, recurrent acute intermittent porphyria (AIP) were free from symptomatic attacks after treatment with…
Adults with erythropoietic protoporphyria (EPP) treated with Scenesse (afamelanotide) spent more time exposed to light in springtime, experienced…
Unusual cases of congenital erythropoietic porphyria (CEP) occurring before birth may lead to miscarriage, as highlighted in a recent…
Acute intermittent porphyria (AIP) attacks can be stopped by regular peritoneal dialysis, a treatment that eliminates waste products by…
The growing incidence of certain types of cancer among the elderly may indicate that an association between acquired erythropoietic uroporphyria…
A rare and severe form of porphyria — congenital erythropoietic porphyria (CEP) — was diagnosed in an infant girl…
A blood stem cell transplant can successfully correct defects in the body’s ability to make heme — a molecule that…
Nearly 25% of people, mostly women, with acute intermittent porphyria (AIP) also have chronic nerve damage — a condition…